10% Owner Entity Linked to Director Buys $8M of Mobia Medical Stock at IPO Price
MOBI is trading near its 52-week low of $11.11 (11% above the low).
Summary
A 10% owner entity, managed by a company director, purchased $8 million in Mobia Medical stock at the IPO price, signaling strong post-IPO insider confidence.
Key Events · Ownership and Investor Activity · MOBI
-
Significant Insider Purchase
An entity linked to a company director and 10% owner purchased $7,999,995 worth of common stock in an open market transaction.
-
Purchase at IPO Price
The shares were acquired at $15.00 per share, which was the IPO price and is above the current market price of $12.34, indicating strong conviction.
-
Post-IPO Conversions
The filing also reports the conversion of pre-IPO convertible notes and preferred stock into common shares, a standard procedure following an initial public offering.
Analysis · MOBI · Industrial Applications And Services
An entity identified as a 10% owner, with a director of Mobia Medical, Inc. as a manager, made a substantial open market purchase of nearly $8 million in common stock. This purchase occurred at the IPO price of $15.00 per share, which is above the current market price of $12.34. This indicates strong conviction from a significant insider group shortly after the company's IPO. Additionally, the filing details the conversion of pre-IPO convertible notes and preferred stock into common shares, a routine event following an IPO.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MOBI was trading at $12.34 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $400.3M. The 52-week trading range was $11.11 to $12.16. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.